STAT stories you may have missed 

Families are reeling after the FDA rejected a therapy for kids born without a thymus gland. 

As Trump looks overseas for drug pricing ideas, one expert says France has some useful approaches. 

'You keep loving each other': Photographer Sofie Mathiassen documented her grandparents' life together while her grandfather progressed through Parkinson's disease and dementia.

Biogen's much-watched presentation on its Alzheimer's drug was tightly choreographed — and, in some regards, unusual.

Opinion: Mike Guerra of the California Life Sciences Association argues that adopting H.R. 3 to lower drug costs would be a pyrrhic victory. 

A new analysis finds some hospitals are spending a larger share of their budgets for new cancer and migraine treatments.